ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transfusion Diagnosis for Donor Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11E17652
Home | Market Reports | Health| Reproductive Health
Global Transfusion Diagnosis for Donor Market Research Report 2024
BUY CHAPTERS

Global Transfusion Diagnosis for Donor Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11E17652
Report
October 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
F.Hoffmann-La Roche
Abbott
Bio Rad Laboratories
Werfen
QuidelOrtho Corporation
Bag Diagnostics GmbH
DiaSorin
Prestige Diagnostics
Atlas Medical GmbH
Lorne Laboratories
AliveDx Holdings Finance

Transfusion Diagnosis for Donor Market

The global Transfusion Diagnosis for Donor market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Blood Banks accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Transfusion Diagnosis for Donor leading manufacturers including Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc., dominate supply; the top five capture approximately % of global revenue, with Grifols leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Transfusion Diagnosis for Donor market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Transfusion Diagnosis for Donor Market Report

Report Metric Details
Report Name Transfusion Diagnosis for Donor Market
Segment by Type
Segment by Application
  • Blood Banks
  • Blood Donation/Transfusion Centers
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, Atlas Medical GmbH, Lorne Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Transfusion Diagnosis for Donor study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Transfusion Diagnosis for Donor Market report?

Ans: The main players in the Transfusion Diagnosis for Donor Market are Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, Atlas Medical GmbH, Lorne Laboratories

What are the Application segmentation covered in the Transfusion Diagnosis for Donor Market report?

Ans: The Applications covered in the Transfusion Diagnosis for Donor Market report are Blood Banks, Blood Donation/Transfusion Centers, Others

What are the Type segmentation covered in the Transfusion Diagnosis for Donor Market report?

Ans: The Types covered in the Transfusion Diagnosis for Donor Market report are Instruments, Kits and Reagents

Recommended Reports

Blood Diagnostics

Blood Collection

Blood Testing Kits

1 Study Coverage
1.1 Introduction to Transfusion Diagnosis for Donor: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Transfusion Diagnosis for Donor Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Kits and Reagents
1.3 Market Segmentation by Application
1.3.1 Global Transfusion Diagnosis for Donor Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Blood Banks
1.3.3 Blood Donation/Transfusion Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transfusion Diagnosis for Donor Revenue Estimates and Forecasts 2020-2031
2.2 Global Transfusion Diagnosis for Donor Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Transfusion Diagnosis for Donor Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Transfusion Diagnosis for Donor Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Instruments Market Size by Players
3.3.2 Kits and Reagents Market Size by Players
3.4 Global Transfusion Diagnosis for Donor Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Transfusion Diagnosis for Donor Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Transfusion Diagnosis for Donor Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Transfusion Diagnosis for Donor Market Size by Type (2020-2031)
6.4 North America Transfusion Diagnosis for Donor Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Transfusion Diagnosis for Donor Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Transfusion Diagnosis for Donor Market Size by Type (2020-2031)
7.4 Europe Transfusion Diagnosis for Donor Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Transfusion Diagnosis for Donor Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Type (2020-2031)
8.4 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Transfusion Diagnosis for Donor Market Size by Type (2020-2031)
9.4 Central and South America Transfusion Diagnosis for Donor Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Transfusion Diagnosis for Donor Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Transfusion Diagnosis for Donor Market Size by Type (2020-2031)
10.4 Middle East and Africa Transfusion Diagnosis for Donor Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Transfusion Diagnosis for Donor Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Business Overview
11.1.3 Grifols Transfusion Diagnosis for Donor Product Features and Attributes
11.1.4 Grifols Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.1.5 Grifols Transfusion Diagnosis for Donor Revenue by Product in 2024
11.1.6 Grifols Transfusion Diagnosis for Donor Revenue by Application in 2024
11.1.7 Grifols Transfusion Diagnosis for Donor Revenue by Geographic Area in 2024
11.1.8 Grifols Transfusion Diagnosis for Donor SWOT Analysis
11.1.9 Grifols Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Features and Attributes
11.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.2.5 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue by Product in 2024
11.2.6 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue by Application in 2024
11.2.7 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue by Geographic Area in 2024
11.2.8 F. Hoffmann-La Roche Transfusion Diagnosis for Donor SWOT Analysis
11.2.9 F. Hoffmann-La Roche Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Business Overview
11.3.3 Abbott Transfusion Diagnosis for Donor Product Features and Attributes
11.3.4 Abbott Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.3.5 Abbott Transfusion Diagnosis for Donor Revenue by Product in 2024
11.3.6 Abbott Transfusion Diagnosis for Donor Revenue by Application in 2024
11.3.7 Abbott Transfusion Diagnosis for Donor Revenue by Geographic Area in 2024
11.3.8 Abbott Transfusion Diagnosis for Donor SWOT Analysis
11.3.9 Abbott Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Corporation Information
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Features and Attributes
11.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.4.5 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue by Product in 2024
11.4.6 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue by Application in 2024
11.4.7 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue by Geographic Area in 2024
11.4.8 Bio-Rad Laboratories Transfusion Diagnosis for Donor SWOT Analysis
11.4.9 Bio-Rad Laboratories Recent Developments
11.5 Werfen
11.5.1 Werfen Corporation Information
11.5.2 Werfen Business Overview
11.5.3 Werfen Transfusion Diagnosis for Donor Product Features and Attributes
11.5.4 Werfen Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.5.5 Werfen Transfusion Diagnosis for Donor Revenue by Product in 2024
11.5.6 Werfen Transfusion Diagnosis for Donor Revenue by Application in 2024
11.5.7 Werfen Transfusion Diagnosis for Donor Revenue by Geographic Area in 2024
11.5.8 Werfen Transfusion Diagnosis for Donor SWOT Analysis
11.5.9 Werfen Recent Developments
11.6 QuidelOrtho Corporation
11.6.1 QuidelOrtho Corporation Corporation Information
11.6.2 QuidelOrtho Corporation Business Overview
11.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Features and Attributes
11.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.6.5 QuidelOrtho Corporation Recent Developments
11.7 AliveDx Holdings Finance
11.7.1 AliveDx Holdings Finance Corporation Information
11.7.2 AliveDx Holdings Finance Business Overview
11.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Features and Attributes
11.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.7.5 AliveDx Holdings Finance Recent Developments
11.8 BAG Diagnostics GmbH
11.8.1 BAG Diagnostics GmbH Corporation Information
11.8.2 BAG Diagnostics GmbH Business Overview
11.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Features and Attributes
11.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.8.5 BAG Diagnostics GmbH Recent Developments
11.9 Diasorin
11.9.1 Diasorin Corporation Information
11.9.2 Diasorin Business Overview
11.9.3 Diasorin Transfusion Diagnosis for Donor Product Features and Attributes
11.9.4 Diasorin Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.9.5 Diasorin Recent Developments
11.10 Prestige Diagnostics
11.10.1 Prestige Diagnostics Corporation Information
11.10.2 Prestige Diagnostics Business Overview
11.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Product Features and Attributes
11.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Atlas Medical GmbH
11.11.1 Atlas Medical GmbH Corporation Information
11.11.2 Atlas Medical GmbH Business Overview
11.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Features and Attributes
11.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.11.5 Atlas Medical GmbH Recent Developments
11.12 Lorne Laboratories
11.12.1 Lorne Laboratories Corporation Information
11.12.2 Lorne Laboratories Business Overview
11.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Product Features and Attributes
11.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (2020-2025)
11.12.5 Lorne Laboratories Recent Developments
12 Transfusion Diagnosis for DonorIndustry Chain Analysis
12.1 Transfusion Diagnosis for Donor Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Transfusion Diagnosis for Donor Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Transfusion Diagnosis for Donor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Grifols S A
F.Hoffmann-La Roche
Abbott
Bio Rad Laboratories
Werfen
QuidelOrtho Corporation
Bag Diagnostics GmbH
DiaSorin
Prestige Diagnostics
Atlas Medical GmbH
Lorne Laboratories
AliveDx Holdings Finance
List of Tables
 Table 1. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Transfusion Diagnosis for Donor Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Transfusion Diagnosis for Donor Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Transfusion Diagnosis for Donor Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Transfusion Diagnosis for Donor Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Transfusion Diagnosis for Donor by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion Diagnosis for Donor as of 2024)
 Table 11. Global Transfusion Diagnosis for Donor Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Transfusion Diagnosis for Donor Companies Headquarters
 Table 13. Global Transfusion Diagnosis for Donor Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Transfusion Diagnosis for Donor Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Transfusion Diagnosis for Donor Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Transfusion Diagnosis for Donor Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Transfusion Diagnosis for Donor Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Transfusion Diagnosis for Donor High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Transfusion Diagnosis for Donor Growth Accelerators and Market Barriers
 Table 25. North America Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Transfusion Diagnosis for Donor Growth Accelerators and Market Barriers
 Table 27. Europe Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Transfusion Diagnosis for Donor Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Transfusion Diagnosis for Donor Investment Opportunities and Key Challenges
 Table 31. Central and South America Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Transfusion Diagnosis for Donor Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Transfusion Diagnosis for Donor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Grifols Corporation Information
 Table 35. Grifols Description and Major Businesses
 Table 36. Grifols Product Features and Attributes
 Table 37. Grifols Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Grifols Revenue Proportion by Product in 2024
 Table 39. Grifols Revenue Proportion by Application in 2024
 Table 40. Grifols Revenue Proportion by Geographic Area in 2024
 Table 41. Grifols Transfusion Diagnosis for Donor SWOT Analysis
 Table 42. Grifols Recent Developments
 Table 43. F. Hoffmann-La Roche Corporation Information
 Table 44. F. Hoffmann-La Roche Description and Major Businesses
 Table 45. F. Hoffmann-La Roche Product Features and Attributes
 Table 46. F. Hoffmann-La Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. F. Hoffmann-La Roche Revenue Proportion by Product in 2024
 Table 48. F. Hoffmann-La Roche Revenue Proportion by Application in 2024
 Table 49. F. Hoffmann-La Roche Revenue Proportion by Geographic Area in 2024
 Table 50. F. Hoffmann-La Roche Transfusion Diagnosis for Donor SWOT Analysis
 Table 51. F. Hoffmann-La Roche Recent Developments
 Table 52. Abbott Corporation Information
 Table 53. Abbott Description and Major Businesses
 Table 54. Abbott Product Features and Attributes
 Table 55. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Abbott Revenue Proportion by Product in 2024
 Table 57. Abbott Revenue Proportion by Application in 2024
 Table 58. Abbott Revenue Proportion by Geographic Area in 2024
 Table 59. Abbott Transfusion Diagnosis for Donor SWOT Analysis
 Table 60. Abbott Recent Developments
 Table 61. Bio-Rad Laboratories Corporation Information
 Table 62. Bio-Rad Laboratories Description and Major Businesses
 Table 63. Bio-Rad Laboratories Product Features and Attributes
 Table 64. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Bio-Rad Laboratories Revenue Proportion by Product in 2024
 Table 66. Bio-Rad Laboratories Revenue Proportion by Application in 2024
 Table 67. Bio-Rad Laboratories Revenue Proportion by Geographic Area in 2024
 Table 68. Bio-Rad Laboratories Transfusion Diagnosis for Donor SWOT Analysis
 Table 69. Bio-Rad Laboratories Recent Developments
 Table 70. Werfen Corporation Information
 Table 71. Werfen Description and Major Businesses
 Table 72. Werfen Product Features and Attributes
 Table 73. Werfen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Werfen Revenue Proportion by Product in 2024
 Table 75. Werfen Revenue Proportion by Application in 2024
 Table 76. Werfen Revenue Proportion by Geographic Area in 2024
 Table 77. Werfen Transfusion Diagnosis for Donor SWOT Analysis
 Table 78. Werfen Recent Developments
 Table 79. QuidelOrtho Corporation Corporation Information
 Table 80. QuidelOrtho Corporation Description and Major Businesses
 Table 81. QuidelOrtho Corporation Product Features and Attributes
 Table 82. QuidelOrtho Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. QuidelOrtho Corporation Recent Developments
 Table 84. AliveDx Holdings Finance Corporation Information
 Table 85. AliveDx Holdings Finance Description and Major Businesses
 Table 86. AliveDx Holdings Finance Product Features and Attributes
 Table 87. AliveDx Holdings Finance Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. AliveDx Holdings Finance Recent Developments
 Table 89. BAG Diagnostics GmbH Corporation Information
 Table 90. BAG Diagnostics GmbH Description and Major Businesses
 Table 91. BAG Diagnostics GmbH Product Features and Attributes
 Table 92. BAG Diagnostics GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. BAG Diagnostics GmbH Recent Developments
 Table 94. Diasorin Corporation Information
 Table 95. Diasorin Description and Major Businesses
 Table 96. Diasorin Product Features and Attributes
 Table 97. Diasorin Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Diasorin Recent Developments
 Table 99. Prestige Diagnostics Corporation Information
 Table 100. Prestige Diagnostics Description and Major Businesses
 Table 101. Prestige Diagnostics Product Features and Attributes
 Table 102. Prestige Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Prestige Diagnostics Recent Developments
 Table 104. Atlas Medical GmbH Corporation Information
 Table 105. Atlas Medical GmbH Description and Major Businesses
 Table 106. Atlas Medical GmbH Product Features and Attributes
 Table 107. Atlas Medical GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Atlas Medical GmbH Recent Developments
 Table 109. Lorne Laboratories Corporation Information
 Table 110. Lorne Laboratories Description and Major Businesses
 Table 111. Lorne Laboratories Product Features and Attributes
 Table 112. Lorne Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Lorne Laboratories Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Transfusion Diagnosis for Donor Product Picture
 Figure 2. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Instruments Product Picture
 Figure 4. Kits and Reagents Product Picture
 Figure 5. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Blood Banks
 Figure 7. Blood Donation/Transfusion Centers
 Figure 8. Others
 Figure 9. Transfusion Diagnosis for Donor Report Years Considered
 Figure 10. Global Transfusion Diagnosis for Donor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Transfusion Diagnosis for Donor Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Transfusion Diagnosis for Donor Revenue Market Share by Region (2020-2031)
 Figure 14. Global Transfusion Diagnosis for Donor Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Instruments Revenue Market Share by Player in 2024
 Figure 17. Kits and Reagents Revenue Market Share by Player in 2024
 Figure 18. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2020-2031)
 Figure 19. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2020-2031)
 Figure 20. North America Transfusion Diagnosis for Donor Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Transfusion Diagnosis for Donor Revenue (US$ Million) in 2024
 Figure 22. North America Transfusion Diagnosis for Donor Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Transfusion Diagnosis for Donor Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Transfusion Diagnosis for Donor Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Transfusion Diagnosis for Donor Revenue (US$ Million) in 2024
 Figure 29. Europe Transfusion Diagnosis for Donor Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Transfusion Diagnosis for Donor Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 32. France Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Transfusion Diagnosis for Donor Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Transfusion Diagnosis for Donor Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Transfusion Diagnosis for Donor Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Transfusion Diagnosis for Donor Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 44. India Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Transfusion Diagnosis for Donor Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Transfusion Diagnosis for Donor Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Transfusion Diagnosis for Donor Revenue (US$ Million) in 2024
 Figure 52. Central and South America Transfusion Diagnosis for Donor Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Transfusion Diagnosis for Donor Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Transfusion Diagnosis for Donor Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Transfusion Diagnosis for Donor Revenue (US$ Million) in 2024
 Figure 58. South America Transfusion Diagnosis for Donor Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Transfusion Diagnosis for Donor Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Transfusion Diagnosis for Donor Revenue (2020-2025) & (US$ Million)
 Figure 64. Transfusion Diagnosis for Donor Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Donor Transfusion Diagnosis Market Research Report 2024
Global Transfusion Bottles Market Research Report 2024
Transfusion Diagnostic Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Molecular Diagnosis of Myelodysplastic Syndrome Market Research Report 2024
Global Home Blood Test Market Research Report 2025
Global Medical Blood Transfusion Market Research Report 2025
Global Sickle Cell Disease Diagnosis Market Insights Forecast to 2030
Global Blood Administration Set Market Research Report 2024
Global Thalassemia Detection Kit Market Research Report 2025
Global Blood Collection Systems Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Molecular Diagnostic Kits Market Research Report 2025
Global Transfusion Technology Market Research Report 2024
Global Blood Transfusion Equipment Market Research Report 2025
Global Blood Group Plate Market Research Report 2024
Global Blood Donor Armchair Market Research Report 2024
Global Disposable Blood Transfusion Market Research Report 2025
Global Private Blood Test Service Market Research Report 2025
Global Blood Culture Test Market Research Report 2025
Viral Diagnostic Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Detection Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions